Category Archives: Health

What is new in the field of Health. Trending topics, and cutting edge research in the are of Health. Press Releases that give us updates on Health.

The Lymphoma Research Foundation Reaches 25-Year Milestone


News Image

Supporting life-saving research, driving awareness, empowering patients and caregivers, and helping to identify and address gaps in care for the lymphoma community has all been at the Foundation’s core for the past 25 years.

The Lymphoma Research Foundation (LRF) – the nation’s largest non-profit organization devoted exclusively to funding innovative lymphoma research and serving the lymphoma community through a comprehensive series of education programs, outreach initiatives, and patient services – honors 25 years of innovation and progress, including the establishment of its elite Scientific Advisory Board (SAB) and legacy of best-in-class educational programs and resources for the lymphoma community.

In 1995, the LRF mission was realized: to eradicate lymphoma – by funding innovative research guided by its elite SAB – and to serve those touched by this disease – by sharing research and treatment insights with members of the lymphoma community through national education programs. Under the leadership of its Founding Chair, Joseph R. Bertino, MD, the SAB began its work with ten members and a commitment to excellence and visionary thinking.

Today, the SAB is world-renowned and comprised of 45 expert lymphoma clinicians and researchers who guide LRF’s research portfolio and offer their expertise to inform LRF’s programming and patient resources. As a result of its elite SAB, LRF has awarded more than $63 million in lymphoma-specific research, to date; and serves more than 1.5 million people in all 50 states and 40 countries through education programs, support services, and digital resources, each year.

“LRF, through its grantees, scientific experts and research program, has influenced every significant breakthrough in the field for the past 25 years,” said Andrew D. Zelenetz, Chair of the LRF Scientific Advisory Board. “The SAB has been instrumental in helping LRF ensure a brighter future for all those touched by lymphoma, and it is my honor to serve as Chair and celebrate this incredible milestone with LRF.”

In the past 25 years:

  • Chronic lymphocytic leukemia (CLL) Hodgkin lymphoma (HL) and non-Hodgkin lymphoma (NHL) mortality rates have decreased by 55 percent , 50 percent and 39 percent, respectively
  • CLL, HL and NHL five-year survival rates have increased by 17 percent, 10 percent and 44 percent, respectively
  • More than 30 drugs to treat lymphoma have been approved by the U.S. Food and Drug Administration (FDA)

“Supporting life-saving research, driving awareness, empowering patients and caregivers, and helping to identify and address gaps in care for the lymphoma community has all been at the Foundation’s core for the past 25 years,” said Steven Eichberg, Chair of the LRF Board of Directors. “I am continuously hopeful and energized by the passion and care exhibited by our researchers, our scientific leadership, our employees, and the lymphoma community—whose work and dedication to LRF mission’s makes an impact each and every day.”

To celebrate its 25-year milestone, LRF reveals its new tagline “Finding Cures Starts Here” and is launching global efforts to support an additional 25 years of innovation and progress:

  • A multi-million commitment and establishment of a new disease-specific initiative (to be revealed in September 2020)
  • A commemorative microsite dedicated to the Foundation’s 25th Anniversary
  • Virtual 25th Anniversary LRF Gala on Sept. 30, which will debut a video series honoring LRF co-founders Barbara and Jerry Freundlich and past SAB Chairs, and highlighting scientific progress made since the Foundation’s inception
  • 25th Annual North American Educational Forum on Lymphoma virtual conference from Oct. 23-25, the largest lymphoma-specific patient conference in the world
  • 10th Anniversary of Blood Cancer Awareness Month (BCAM) and its BCAM initiative Light it Red for Lymphoma by illuminating buildings, monuments and landmarks worldwide in glowing red lights
  • Virtual 14th Annual Lymphoma Research Ride on Oct. 4, an outdoor cycling fundraising event for children and adults of all experience levels


“The Lymphoma Research Foundation has always been committed to making an impact on the lymphoma community,” said Meghan Gutierrez, Chief Executive Officer at LRF. “The awareness we have brought to the needs of people with lymphoma, the innovative lymphoma research and scientific thought leadership we have supported, and the patients and caregivers we have empowered brings us great hope, and fuels the Foundation’s path ahead to a world without lymphoma.”

Support of the Lymphoma Research Foundation 25th Anniversary and efforts include AstraZeneca, Bristol Myers Squibb, Genentech, Inc., and Karyopharm Therapeutics.

To support the 25th Anniversary of the Lymphoma Research Foundation, visit lymphoma.org/25, follow LRF on social media and use #LRFCures25.

About the Lymphoma Research Foundation

The Lymphoma Research Foundation (LRF) is the nation’s largest non-profit organization devoted to funding innovative research and serving the lymphoma community through a comprehensive series of education programs, outreach initiatives and patient services. To date, LRF has awarded more than $63 million in lymphoma-specific research. For additional information on LRF’s research, education and services, visit lymphoma.org.

Share article on social media or email:

Binary Fountain Named to 2020 Inc. 5000 List of America’s Fastest-Growing Companies


Binary Fountain + Inc 5000

Especially at a time like this, we’re grateful to our customers for trusting us to help their brands grow, build customer loyalty, increase their revenue, and push the limits of our technology.

Binary Fountain, the leading customer experience and online reputation management platform for enterprises, healthcare organizations and small and medium-sized businesses, was selected as an honoree for the 2020 Inc. 5000 list.

Binary Fountain ranks No. 800 on the list of America’s fastest-growing private companies, with explosive growth in revenue over the past three years.

“We’re honored to be included on a list of such high-caliber businesses, and I’m proud of the work our team has done – and continues to do – to enhance our customer experience management platform and expand into new industries,” said CEO Ramu Potarazu. “Especially at a time like this, we’re grateful to our customers for trusting us to help their brands grow, build customer loyalty, increase their revenue, and push the limits of our technology.”

Binary Fountain’s high growth rate was bolstered by several key enterprise client wins and partnerships, along with the launch of new products and services for local listings, social media management, and employer brand management. The 7-year-old company also hit a milestone of 15 million customer reviews collected and analyzed by its platform in 2019 alone.

“Our recent milestones and business growth reflect our commitment to first-class customer service,” Potarazu said, “and our commitment to equipping businesses to engage consumers and strengthen their brand, especially as consumer behavior rapidly evolves.”

Trusted by thousands of unique brands across North America, Binary Fountain comprises several leading solutions for managing online listings, reviews, surveys and brand reputation. Its customer experience and reputation management platform currently tracks and analyzes consumer feedback for more than 900,000 healthcare providers and serves over 450 organizations, many of which are large global enterprises.

“The companies on this year’s Inc. 5000 come from nearly every realm of business,” said Inc. editor-in-chief Scott Omelianuk. “From health and software to media and hospitality, the 2020 list proves that no matter the sector, incredible growth is based on the foundations of tenacity and opportunism.”

Complete results of the Inc. 5000, including company profiles and an interactive database can be found here. The annual Inc. 5000 event honoring the companies on the list – including Binary Fountain – will be held virtually in October.

Binary Fountain was also recently named to Deloitte’s Technology Fast 500 list of the nation’s fastest-growing technology companies.

About Binary Fountain

Binary Fountain provides the leading customer experience and online reputation management platform for enterprises, healthcare organizations and small and medium-sized businesses. Anchored in its Natural Language Processing (NLP) technology, the cloud-based platform mines customer and employee feedback from surveys, online ratings and review sites, social media and other data sources to equip organizations with actionable insights needed to improve brand loyalty, increase engagement, attract new customers and drive sustainable bottom-line results. On a mission to help companies grow their business and create better customer experiences, Binary Fountain serves various industries including healthcare, hospitality, retail, automotive and financial services. For more information, visit http://www.binaryfountain.com or follow on Twitter @binaryfountain.

Methodology

The 2020 Inc. 5000 is ranked according to percentage revenue growth when comparing 2016 and 2019. To qualify, companies must have been generating revenue by March 31, 2016. They had to be U.S.-based, privately held, for profit, and independent—not subsidiaries or divisions of other companies—as of December 31, 2019. The minimum revenue required for 2016 was $100,000; the minimum for 2019 was $2 million.

Binary Fountain Media Contact

Kieran McQuilkin

kmcquilkin@binaryfountain.com

(703) 635-2104‬

Share article on social media or email:

SightMD Announces Strategic Partnership with Larry P. Berstein, M.D., F.A.A.O.


SightMD, a multi-specialty ophthalmology platform, today announced a strategic partnership with Larry P. Berstein, M.D., F.A.A.O, a Nassau County-based ophthalmologist.

SightMD, a multi-specialty ophthalmology platform, today announced a strategic partnership with Larry P. Berstein, M.D., F.A.A.O., a Nassau County-based ophthalmologist. Sight Growth Partners, the administrative services provider for SightMD, will also serve Dr. Berstein in all administrative matters. The acquisition represents SightMD’s first office in Plainview, with Dr. Berstein bringing 35+ years of ophthalmic experience to SightMD’s growing team of over 80 providers and 39 convenient locations in the greater tri-state area.

SightMD has continued to serve the community throughout the COVID-19 pandemic. Our commitment and dedication to our patients have never been interrupted. SightMD continues to expand and look for additional practices and doctors that align with our values and patient-first mindset.

Dr. Berstein graduated from Boston University. He went on to complete both his Internship in Internal Medicine and Residency in Ophthalmology at Montefiore Hospital & Medical Center (Albert Einstein College of Medicine and Affiliated Hospitals) where he was Chief Resident in Ophthalmology from 1981-1982. Dr. Berstein is a former Assistant Clinical Professor of Ophthalmology at the Albert Einstein College of Medicine. He has held appointments as Chief of Ophthalmology, President of the Medical Staff, and was a Member of the Board of Directors at Plainview Hospital (now part of Northwell Health).

“As we continue to expand our practice, we’re fortunate to be able to welcome a physician with the skill and reputation of Dr. Berstein to our growing SightMD family,” said Jeffrey Martin, M.D., a Co-Founder and CEO of SightMD. “Dr. Berstein has built a legacy of superior patient care and is very well known in the Nassau County ophthalmology community. He has always been on the forefront of our specialty’s patient care advancements and we could not be more excited to partner with him at his Plainview office.”

Dr. Berstein added, “I joined SightMD because I wanted to be affiliated with the patient-centric quality of care and level of excellence that SightMD stands for and has demonstrated in the community; always putting patients first and striving to meet their needs and improve their quality of life. This belief system is in line with mine and is how I have practiced ophthalmology my entire career, which is why I knew it would be a great fit. The COVID-19 pandemic reinforced why I wanted to join the SightMD family. The resilience and commitment shown by everyone at SightMD made me 100% confident in my choice.”

Jonathan Lujan, CEO of Sight Growth Partners, added, “Sight Growth Partners continues to be committed to its mission of easing the administrative burden of physicians so they can focus on the patients. Despite the challenges faced by our community and the nation due to COVID-19, we continue to partner with and empower blue-chip providers like Dr. Berstein.”

Dr. Berstein will continue to care for his patients at the same Plainview office. With this partnership, Dr. Berstein’s patients and the community in central Nassau County will have access to seamless care at all of SightMD’s office locations throughout Long Island, Westchester and New York City. Dr. Berstein’s new affiliation with SightMD brings his patients and the community new services including, laser cataract surgery, LASIK laser vision correction, pediatric ophthalmology, facial cosmetic and reconstructive eye surgery, audiology, refractive surgery, glaucoma management, retinal and diabetic eye disease treatment and advanced cataract care. SightMD’s strategic partnership with Dr. Berstein represents the twelfth practice to join the Company since Sight Growth Partners partnered with Chicago Pacific Founders in September 2018.

About SightMD

SightMD is a rapidly-growing integrated ophthalmic provider group, offering patients access to over 60 ophthalmic surgeons and specialists through the convenience of 39 locations across downstate New York. SightMD’s track record of providing clinically-excellent care spans over 50 years, and its services include laser cataract surgery and lens implantation, glaucoma management, retinal disorder treatment, corneal services, neuro-ophthalmology, LASIK laser vision correction, oculoplastic surgery, pediatric ophthalmology, and audiology. For more information about SightMD, please visit http://www.sightmd.com ###

About Sight Growth Partners

Sight Growth Partners is a leading management services organization serving the ophthalmology sector. It has over 100 employees who provide administrative solutions to physicians, ophthalmology clinics and ambulatory surgery centers. Sight Growth Partners provides its clients with world-class administrative services, including a 24/7 call center, billing, credentialing, human resources and other services, enabling them to continue delivering best-in-class care to patients in their communities. Sight Growth Partners is backed by Chicago Pacific Founders, a leading middle market private equity firm which focuses exclusively on partnerships with growing companies in the healthcare services sector. For more information about Sight Growth Partners, please visit http://www.sightgrowthpartners.com. ###

Share article on social media or email:

American Family Care Named to Inc. 5000 List for the Sixth Time


Our healthcare network has tripled in size over the last eight years. We’ve grown from 80 to more than 220 clinics, and the pandemic is not slowing us down. We are on track to open our 500th location by 2025.

For the sixth time, American Family Care (AFC), the nation’s leading provider of urgent care, accessible primary care and occupational medicine, has earned a spot on the prestigious Inc. 5000 list. This year, Birmingham-based AFC is at No. 4697, with 64 percent growth over the last three years.

“We are delighted once again to be among the fastest-growing companies in the United States,” said D. Bruce Irwin, M.D., Founder and CEO of American Family Care. “I cannot understate the fact our success is the direct result of the compassionate, convenient health care our employees and franchisees are delivering to patients around the nation.”

American Family Care is a healthcare network with more than 220 locations. AFC stands out from other urgent care centers by offering a consistent, state-of-the-art treatment across a broad range of services — on the spot. Doctors diagnose and treat illnesses, traumas and sports injuries, including minor surgical procedures. Physicians also dispense medication, plus the facility is equipped to x-ray and set broken bones. Pre-employment physicals, drug screening and treatment of work-related injuries are also available.

The latest ranking on the Inc. 5000 list is a testament to AFC’s stupendous growth over a very short time.

“Our healthcare network has tripled in size over the last eight years. We’ve grown from 80 to more than 220 clinics, and the pandemic is not slowing us down. We are on track to open our 500th location by 2025,” explains Sean Hart, Vice President of Sales and Development. “We have the resources to give entrepreneurs the tools they need to succeed in this business. From band-aids to x-ray machines to custom telehealth software, we connect our franchise owners to what they need to provide the quality of medical care AFC patients have grown to expect when they walk into one of our clinics.”

In 1982, Inc. magazine introduced the Inc. 500 list of the fastest-growing privately held companies in the United States. In 2007, the Inc. 500 list expanded to the Inc. 5000, giving readers a deeper, richer understanding of the entrepreneurial landscape and capturing a broader spectrum of success. This prestigious list of the nation’s most successful private companies has become the hallmark of entrepreneurial success and the place where future household names first make their mark.

Inc. 5000 Methodology

The 2020 Inc. 5000 is ranked according to percentage revenue growth when comparing 2016 and 2019. To qualify, companies must have been founded and generating revenue by March 31, 2016. They had to be U.S.-based, privately held, for-profit, and independent—not subsidiaries or divisions of other companies — as of December 31, 2019. (Since then, a number of companies on the list have gone public or been acquired.) The minimum revenue required for 2016 is $100,000; the minimum for 2019 is $2 million.

About American Family Care:

Founded by Dr. Bruce Irwin with a single location in 1982, American Family Care has pioneered the concept of convenient, patient-centric healthcare. Today, with more than 200 clinics and 600 in-network physicians caring for nearly 3 million patients a year, AFC is the nation’s leading provider of urgent care, accessible primary care and occupational medicine. Ranked by Inc. magazine as one of the fastest-growing companies in the U.S., AFC’s stated mission is to provide the best healthcare possible, in a kind and caring environment, while respecting the rights of all patients, in an economical manner, at times and locations convenient to the patient. For more information, visit http://www.AmericanFamilyCare.com.

Share article on social media or email:

Tampa cancer specialist earns society honors


Dr. Howard McLeod

It’s always an honor to be recognized by your peers.”

Dr. Howard McLeod, medical director at the Geriatric Oncology Consortium, has earned honors from the American Society of Clinical Oncology (ASCO).

Dr. McLeod earned the Fellow of the American Society of Clinical Oncology (FASCO) distinction for extraordinary volunteer service, dedication, and commitment from ASCO, the largest society of cancer treatment specialists in the world. His contributions include recent work chairing the annual New Drug Symposium, being a founding editor on the journal JCO: Precision Oncology, chairing the FDA Critical Path Subcommittee and chairing a TAPUR clinical study tumor board.

Dr. McLeod is the first cancer specialist in the Tampa area to receive the FASCO designation and the third in Florida. Dr. McLeod and Dr. Merry Jennifer Markham of the University of Florida received the designation this year.

“It’s always an honor to be recognized by your peers,” said Dr. McLeod. “The work we are doing to personalize treatment is important so when recognition comes it is deeply appreciated,” he said.

Dr. McLeod works with the USF Taneja College of Pharmacy and the Geriatric Oncology Consortium. Dr. McLeod is an international expert in Precision Medicine, allowing patients to receive therapy aligned with their individual genetic code.

Precision Medicine is an emerging approach to treatment and prevention that considers individual variability in genes, environment, and lifestyle.

This approach allows doctors and researchers to predict which treatment and prevention strategies will work for a disease in certain groups of people, according to the U.S. National Library of Medicine.

In addition to his clinical and research duties, McLeod founded several Florida-based biomedical companies, including Interpares Biomedicine, which won BioFlorida’s 2017 BioPitch Competition.

In June, Dr. McLeod was part of ASCO’s three-day virtual scientific meeting, originally scheduled for Chicago. More than 42,700 attendees from 138 countries participated, learning virtually about new clinical cancer advances in every area of cancer research.

“With half of attendees joining from outside the U.S., this was truly an international meeting of the minds,” said Howard A. “Skip” Burris III, then president of ASCO. “It is exciting to think how many new connections were made and collaborations were sparked. The next big cancer breakthrough could very well come from one of the virtual conversations that began at this meeting.”

About ASCO:

Founded in 1964, the American Society of Clinical Oncology, Inc. (ASCO®) is committed to making a world of difference in cancer care. As the world’s leading organization of its kind, ASCO represents nearly 45,000 oncology professionals who care for people living with cancer. Through research, education, and promotion of the highest-quality patient care, ASCO works to conquer cancer and create a world where cancer is prevented or cured, and every survivor is healthy. ASCO is supported by its affiliate organization, the Conquer Cancer Foundation. Learn more at http://www.ASCO.org, explore patient education resources at http://www.Cancer.Net, and follow us on Facebook, Twitter, LinkedIn, and YouTube.

MEDIA CONTACT: David Fierro (david@dfierrocommunications.com) 850.815.1621

Share article on social media or email:

The Dental Studio of Midland Secures Loose Dentures with Dental Implants in Midland, TX


The Dental Studio of Midland, Dentists in Midland, TX

The Dental Studio of Midland Offers Secure Implant Supported Dentures in Midland, TX

Using the strength and durability of dental implants, the dentists can stabilize a removable denture and improve dental function for biting and chewing.

Drs. Tye Thompson, Jordon Green, and Mallory Gonzales of The Dental Studio of Midland welcome new patients who have loose dentures in Midland, TX and encourage them improve their function and health with implant supported dentures. The team offers comprehensive dental care in their state-of-the-art practice, including denture stabilization with dental implants for those with ill-fitting dentures. In an effort to provide convenient care in fewer visits, especially amid the COVID-19 pandemic, they do not require a referral for implant supported dentures treatment.

Traditionally, removable dentures have been the long-standing option for patients missing all their teeth. While able to restore the appearance of a smile, dentures have numerous limitations that most patients find embarrassing or discouraging. Dentures only restore 10 percent of biting and chewing power, which significantly limits food choices and can lead to a decline in oral and overall health. Dentures also rely on natural suction and adhesives to remain in place, but can easily become loose when a person eats, talks, or laughs. Additionally, dentures do not address the bone loss that naturally occurs in the jaw without stimulation from teeth. Over time, dentures become looser and ill-fitting, increasing the risk of gum sores, infection, and other problems associated with increased denture mobility.

The experienced team of dentists at The Dental Studio of Midland provides a solution for patients struggling with loose dentures. Using the strength and durability of dental implants, the dentists can stabilize a removable denture and improve dental function for biting and chewing. These implant supported dentures are comprised of two or more dental implants onto which a denture is attached, so it no longer takes support from the gums and adhesives. The team of dentists place and restore dental implants in their comprehensive practice using advanced technologies, including CBCT imaging and 3D printing, to provide predictable and personalized treatments. Their skills also extend to tooth extractions, bone grafting, sedation dentistry, and other procedures related to dental implants. They also hand-craft custom dentures in their office as the patient heals from surgery, which will then be permanently fixed to the dental implants.

Patients with ill-fitting and loose dentures can experience amazing benefits of secure implant supported dentures, including:

  • Stable teeth for proper biting and chewing
  • Secure smile without suction or adhesives
  • No denture slipping, clicking, or falling out
  • Easy maintenance and cleaning
  • Improved oral and overall health
  • Boost in confidence and quality of life

The dentists of The Dental Studio of Midland welcome patients with missing teeth and loose dentures in Midland, TX to restore their quality of life with implant supported dentures. Patients are encouraged to schedule an appointment, with or without a referral, by visiting http://www.midlanddentalstudio.com or calling 432-687-0629.

About the Practice

The Dental Studio of Midland offers comprehensive and caring dental care to patients in Midland, TX. Committed to serving custom care that patients truly need, Drs. Tye Thompson, Jordon Green, and Mallory Gonzales build relationships with each patient in order to understand their unique needs and goals. Both Drs. Thompson and Green completed dental training at the prestigious University of the Pacific and continue to expand their knowledge in dentistry by attending multiple continuing education courses. Dr. Gonzales brings her experience from the University of Texas to the team. The Dental Studio of Midland is equipped with advanced dental technology to provide patients with the highest standard of care. Drs. Thompson, Green, and Gonzales all bring their unique art and “niche” to The Dental Studio of Midland. Some of the services offered are laser dentistry, Invisalign®, full mouth reconstruction, and sedation dentistry. The Dental Studio of Midland team is dedicated to providing the most efficient, least painful procedures for patients, and offer minimally invasive surgery whenever possible. To learn more about Drs. Thompson, Green, and Gonzales and the services offered at The Dental Studio of Midland, call 432-687-0629 or visit http://www.midlanddentalstudio.com.

Share article on social media or email:

Tergus Pharma Receives 2020 Customer Value Leadership Award


Tergus Pharma Receives 2020 Customer Value Leadership Award

“Tergus is positioning well to provide unmatched services to specialty pharma, spanning through clinical R&D to commercial manufacturing, strengthening its leadership as an outsourcing contract services provider in dermatology.”

Tergus Pharma, an end-to-end service provider for topical pharmaceutical research, drug development, testing and commercial manufacturing company, has been an industry leader for several years with a state-of-the-art facility in Durham, North Carolina. The company has a long and stellar reputation for delivering quality results to clients from formulation through manufacturing and is now being recognized by Frost & Sullivan for this unfailing commitment to Client satisfaction.

From the Frost & Sullivan report:

“With the contract research organization (CRO) dermatology segment constituting only 5% of the global market, specialty pharmaceutical (pharma) companies advancing topical drugs through research and development (R&D) must rely on multiple CROs at different stages to complete testing.

“Tergus Pharma (Tergus) provides full CRO services for therapeutics in dermatology. The company continually builds on technical, professional, and structural capabilities to meet customers’ performance needs, gaining a sterling worldwide reputation along the way. Additionally, Tergus’ customer-centric flexible and tailored services deliver a real partner-level engagement, regardless of project size. Always forward focused on customer’s goals and commercialization needs, the company invested in an over 100,000 square foot facility for its transition towards a full-fledged contract development and manufacturing organization. Tergus is positioning well to provide unmatched services to specialty pharma, spanning through clinical R&D to commercial manufacturing, strengthening its leadership as an outsourcing contract services provider in dermatology.”

Dr. Vijendra Nalamothu, Chairman and CEO of Tergus Pharma responded to the news by saying, “We are delighted to accept this prestigious award from Frost & Sullivan. Our focus has always been on Quality, Science and Delivery. We know if we excel in these three areas and apply this excellence to every Client interaction, every project, every time, we will continue to provide outstanding value to our customers.”

About Tergus Pharma:

Tergus Pharma is a world leading topical CDMO; FDA inspected, cGMP certified laboratory. Tergus’ topical experts have assisted with the advancement of 100’s of topical products providing R&D, release and skin testing, and manufacturing of Toxicology, Clinical trial materials and Commercial products. With the new manufacturing facility set to open in January 2021, Tergus is set to be the largest Topical CDMO in the industry. Learn more at http://www.TergusPharma.com

About Frost & Sullivan:

Frost & Sullivan is a business consulting firm involved in market research and analysis, growth strategy consulting, and corporate training across multiple industries. It is headquartered in Mountain View, California, and has 40 offices on six continents

Share article on social media or email:

Point-of-Care Partners Expands Team in Response to Unprecedented Changes in Healthcare Landscape


Point-of-Care Partners

Improving healthcare through technology has never been more important — or achievable —than it is now.

Today, Point-of-Care Partners (POCP) announced the expansion of its team to more fully integrate emerging areas of health IT innovation within its consultancy including building interoperability roadmaps, meeting requirements of CMS and ONC rules, payer/provider data collaboration, the shift to value-based care and patient engagement. New recent team members will enable POCP to further advance healthcare transformation in the following areas:

1. Standards Development/Technical Support: Frank McKinney, Phung Matthews and Kim Ball will support Point-of-Care Partners’ efforts to advance adoption of industry standards and provide technical expertise to POCP clients embarking on new initiatives requiring the application of emerging standards and use cases. Examples include new patient-facing FHIR applications, efforts to automate manual tasks such as prior authorization using HL7 FHIR and developing use cases to support oncology treatment and research.

2. Interoperability: Seven new team members will support the advancement of healthcare interoperability across stakeholders with emphasis on:


  • Health Information Exchange: Ed Daniels and Sharon Adams will support POCP clients actively working to improve interoperability, care management and coordination. Examples include the exchange of clinical and financial data among hospitals, physician practices, clinical laboratories and insurance plans as well as the sharing of healthcare data such as advance care planning documents.
  • Payer Interoperability: New team members who will focus on increasing interoperability between payers and the healthcare ecosystem include Gary Austin, Vanessa Candelora, Keith Crossley, Michael Kreitzer and Deb Markson. This newly formed team will work hand-in-glove with payer organizations to help with their transitions to value-based care including the formation of new clinical initiatives focused on improving population health and healthcare quality. They will also work with organizations to execute transformative strategies that provide new capabilities and improve performance and quality and support compliance with the CMS and ONC Interoperability Final Rules.

POCP also significantly expanded its account management team to enhance client engagement and project efficiency. New team members include Stefanie Dobes, Jordyn King, Olga Mogilenko and Emma Laux, who will also support the Marketing team.

“Improving healthcare through technology has never been more important — or achievable —than it is now. Due to regulatory drivers such as this year’s Federal Interoperability Rules and multi-stakeholder initiatives such as the Da Vinci Project, healthcare technology is rapidly evolving to support more patient-centric care delivery and the critical interoperability needed to better support pandemic response efforts,” said Tony Schueth, CEO and Managing Partner of Point-of-Care Partners. “Point-of-Care Partners’ team members are passionate about improving healthcare delivery by helping our clients use health IT in innovative ways that make a real difference in patient lives. Our recent growth will enable us to make an even bigger impact at this critical time in healthcare delivery.”    

To view new team member bios and POCP’s full team, visit POCP’s website.

About Point-of-Care Partners

Point-of-Care Partners is a health IT management consulting firm with in-depth expertise in ePrescribing, eMedication management, health information exchange, population health management and multi-stakeholder initiatives. To learn more about how Point-of-Care Partners can help your company leverage health IT to improve healthcare delivery and quality of patient care, contact us at info@pocp.com.

Related Links:

About Point-of-Care Partners(Video)

The Dish on Health IT

POCP Events

LinkedIn Profile

Share article on social media or email:

SuperCare Health’s COVID-19 Telemonitoring Program Delivers On Managing Respiratory Health Of Optum Patients


SuperCare Health’s respiratory therapists monitor COVID-19 patients remotely through telemedicine

“This has been a great demonstration of SuperCare Health’s creativity, agility, and dedication to patient partnership,” said Dr. Curtis Sather, Medical Director, Optum.

In response to the unprecedented COVID-19 pandemic, SuperCare Health and Optum collaborated to create a COVID-19 Telemonitoring Program that allows symptomatic patients to be monitored and to recover in their homes, avoiding unnecessary hospitalizations.

When Dr. Curtis Sather, Medical Director and pulmonologist at Optum, thought about developing a COVID-19 monitoring program, he did not hesitate to immediately contact SuperCare Health. He knew close respiratory monitoring would be vital in setting up alternative care for people who were confirmed for, or potentially had, COVID-19 but didn’t require hospitalization. “I knew SuperCare Health had the background and the know-how to put something like this together,” said Dr. Sather

Albert Ramos, an analyst with Optum, discussed the promptness people demonstrated in deploying the COVID-19 Telemonitoring Program. “Everyone understood how timely this resource was,” he said. It also helped that SuperCare Health was already equipped with everything needed for this program.

Paula Dahl, Executive Vice President of Strategy and Business Development, emphasized that SuperCare Health is a respiratory disease management company that has specialized in and has developed a variety of programs for people with respiratory conditions for years, so it was a natural progression to adapt these proven clinical models to assist COVID-19 patients in this time of crisis.

Dahl credits part of SuperCare Health’s ability to deploy a solution for COVID-19 patients to the fact that SuperCare already had the framework established within their iBreathe COPD readmission prevention program™. The clinical pathway included the ability to spot check SpO2 blood oxygen saturation, capture daily health monitoring question responses based on the Borg dyspnea score and other ADLs to the SuperCare Health Clinical electronically. This daily tracking allows SuperCare Health teams to intervene in the patients’ care promptly and appropriately, work with the Optum teams on escalations and ongoing communication aimed at helping this high-risk patient population get the care they need.

Oxygen therapy is an essential part of this innovative remote treatment, and Dr. Sather is to credit for this realization. COVID-19 is a disease different from others not just because of how quickly patients can become ill, but also because of how it can affect oxygenation before symptoms are displayed.

Dr. Sather discussed how he made the connection that oxygen was needed for a patient’s recovery. With the information he knew about oxygen’s role in COVID-19, he realized O2 would be key to monitoring a patient’s success and not ventilation.

Dr. Sather explains that, when avoiding relapse, a common concern with COVID-19 patients is the difficulty in determining the severity of a patient’s case.

“Monitoring is important because when you see someone at one point in the disease you don’t necessarily know [its] trajectory,” he went on to say.

When asked if relapse is inevitable, Dr. Sather said, “Unfortunately, we don’t have proven effective disease treatment, so the name of the game is ID’ing patients that need to be in the hospital versus those who can have home care.” However, he stated that there seems to be reports of patients feeling grateful after being monitored closely and even said that among medical groups, there appears to be a consensus that telemedicine will continue to be an important part of healthcare moving forward.

While reflecting on the decision to include SuperCare Health in this collaboration Dr. Sather was asked if he would partner with SuperCare Health in the future on other programs, and he did not hesitate to say he “absolutely would.” He confidently responded, “This has been a great demonstration of SuperCare Health’s creativity, agility, and dedication to patient partnership.”

Mr. Ramos also showed an interest in partnering with SuperCare Health on future programs. He said he was meeting with SuperCare Health every day and felt this relationship made the process significantly easier. “To get this kind of commitment in return is nice,” he said.

He also appreciated that whenever his team communicated with SuperCare Health, they were able to access channels and were able to get prompt responses.

SuperCare Health is proud of its ability to swiftly respond to the COVID-19 pandemic by partnering with Optum to create this respiratory COVID-19 Telemonitoring Program.

SuperCare desires to continue to develop and deploy impactful clinical programs that allow patients to recover in the comfort of their homes. This is a big win for patients and the healthcare community as a whole. If working with an innovative healthcare provider with a consistent track record of developing proven cost-saving care models is something you value, we highly encourage you to consider contacting SuperCare.

We are still living in a time with plenty of uncertainty and this can feed our fears and anxieties about the future, but the telemonitoring program offers a proven method for patients to manage those concerns and their health.

“As parts of our communities begin to reopen their doors, we want to assure everyone that SuperCare stands ready to provide the highest level of support for those courageously managing their respiratory symptoms,” said Dahl. SuperCare Health is here and ready to assist with these new methods to allow COVID-19 patients to recover from the comfort of their homes.

Although there is still plenty to learn, we have made great strides and know we can overcome this together.

About SuperCare Health

SuperCare Health is a comprehensive high-touch, high-tech, post-acute health care organization that manages chronic care patients and provides a broad range of therapies including ventilation, oxygen, CPAP/BiPAP, medication optimization, and airway clearance and mobilization. Utilizing cutting-edge mobile technologies combined with quality clinical services, SuperCare Health has proven cost savings that reduce hospital readmissions and offer shared savings for payors.

For more information, visit supercarehealth.com or request a meeting at bit.ly/mdsolution.

Medrio, Inc. Names Nicole Latimer as Chief Executive Officer


“We are fortunate to have someone of Nicole Latimer’s caliber and experience to lead Medrio into the future. I am confident that Nicole will take Medrio to the next level while remaining true to our values.” – Mike Novotny

Medrio Inc., the leading provider of eClinical technology to pharmaceutical, biotech, medical device, diagnostics, and animal health markets, announced the appointment of Nicole Latimer to Chief Executive Officer. Nicole will be replacing Mike Novotny, former CEO and Founder of Medrio as he has chosen to take a sabbatical after leading Medrio’s growth for 15 years. Mike will, however, remain on the Board of Directors.

Effective today, Nicole will be responsible for the continued growth and commitment of Medrio to cure all disease with clinical trial technology.

Prior to joining Medrio, Nicole was CEO of StayWell, where she drove the company’s mission to be the premier provider of lifestyle risk management programs for the entire healthcare ecosystem, leveraging behavioral science as the foundation for improving health outcomes. Nicole has also led key initiatives for the Advisory Board and Deloitte Consulting, focusing on population health management, health system growth strategies, patient and employee education, and SaaS development and delivery.

Speaking on behalf of the Board of Directors, Mike Novotny said “We are fortunate to have someone of Nicole Latimer’s caliber and experience to lead Medrio into the future. She brings decades of experience in leadership, services, and devices, and she brings a unique perspective of patient insights at a time when patient advocacy demands attention in clinical trials. I am confident that Nicole will take Medrio to the next level while remaining true to our values.”

“I would like to thank Mike Novotny for his leadership, entrepreneurial spirit, and vision for the future of the organization. Since its inception in 2005, Mike has done a tremendous job cultivating a team of creative and talented individuals whose determination is evidenced by the loyalty and success of our customers. I am excited to take the reins of this incredible company and grateful for the Board’s confidence in my leadership. I am particularly fortunate to be surrounded by such a talented team as we take this company into the future,” said Nicole Latimer, CEO, Medrio.

About Medrio

Medrio is the leading provider of eClinical technology for pharma, device, and diagnostics clinical trials. Founded in 2005, the company’s cloud-based EDC, Direct Data Capture, eConsent, and ePRO solutions deliver fast, flexible, and easy-to-use tools for the collection and management of clinical data and patient-reported outcome responses. Study sponsors and Contract Research Organizations have used Medrio extensively in clinical trials across a wide array of therapeutic areas, with notable success in oncology, infectious disease, and more. Medrio has extensive experience in all study phases and leads the market in early-phase trials. The company serves over 600 customers globally, with headquarters in San Francisco and offices in numerous domestic and international locations. For more information, please visit http://www.medrio.com.

Share article on social media or email: